文献速递脊柱关节炎其他结缔组织病

足跟附着点炎MRI评分系统(HEMRIS)与临床附着点炎及PET-CT局部代谢活性的比较

Comparison of the Heel Enthesitis MRI Scoring System (HEMRIS) with clinical enthesitis and local metabolic activity on PET-CT.
PubMed 文献 · RMD Open · 2020-01-01

这项前瞻性观察研究纳入38例银屑病、银屑病关节炎或强直性脊柱炎患者,比较HEMRIS与临床附着点炎及PET/CT局部代谢活性。结果显示临床附着点炎的跟腱HEMRIS结构损伤评分显著更高(中位数1.0 vs 0.5,p=0.04),但临床未受累附着点中HEMRIS异常常见(跟腱63%,足底筋膜33%),且与PET/CT代谢活性仅弱相关。

要点

  • 临床附着点炎的跟腱HEMRIS结构损伤评分显著高于无临床附着点炎者。
  • 临床未受累的跟腱和足底筋膜中HEMRIS异常发生率分别为63%和33%。
  • 跟腱HEMRIS结构评分和总评分与PET/CT局部代谢活性仅弱相关。

核心结论

  • HEMRIS异常在临床未受累附着点中高发,且与临床和PET/CT表现存在不一致。
  • HEMRIS可能是检测跟腱和足底筋膜附着点炎炎症及结构病变的敏感方法,但MRI表现的临床意义尚需纵向研究确定。

研究设计与样本

  • 前瞻性观察性研究,纳入38例银屑病、银屑病关节炎或强直性脊柱炎患者,无论是否存在临床足跟附着点炎。
  • 采集双踝MRI和全身18F-FDG PET/CT,由两名独立盲法观察者按HEMRIS评估附着点炎,由对影像结果盲法的医师临床评估跟腱和足底筋膜附着点炎。

主要发现

  • 共按HEMRIS评分并临床评估146个附着点,其中6个临床受累。
  • 临床附着点炎的跟腱HEMRIS结构损伤评分显著高于无临床附着点炎者(中位数1.0 vs 0.5,p=0.04)。
  • 临床未受累附着点中,HEMRIS异常见于44/70(63%)跟腱和23/70(33%)足底筋膜。
  • 跟腱PET/CT局部代谢活性与HEMRIS结构评分(rs=0.25,p=0.03)和总评分(rs=0.26,p=0.03)呈弱相关。

临床怎么用

  • HEMRIS可用于检测跟腱和足底筋膜的亚临床附着点炎及结构病变,但需结合临床评估解读。
  • HEMRIS异常与临床附着点炎及PET/CT代谢活性的一致性有限,不宜单独作为治疗决策依据。

局限性

  • 临床受累附着点数量少(仅6个),可能影响比较的稳健性。
  • MRI表现的临床意义尚未在纵向研究中确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the Heel Enthesitis MRI Scoring model (HEMRIS) with clinical and PET/CT outcomes in patients with cutaneous psoriasis (Pso), psoriatic arthritis (PsA) or ankylosing spondylitis (AS). METHODS: This prospective, observational study included 38 patients with Pso, PsA and AS. Patients were included regardless of presence or absence of clinical heel enthesitis. MRI-scans of both ankles and a whole-body 18F-FDG PET/CT were acquired. MRIs were assessed for enthesitis by two independent and blinded observers according to the HEMRIS. A physician, blinded for imaging results, performed clinical evaluations of enthesitis at the Achilles tendon and plantar fascia. RESULTS: In total, 146 entheses were scored according to the HEMRIS and clinically assessed for enthesitis (6 entheses were clinically affected). In Achilles tendons with clinical enthesitis, the HEMRIS structural damage score was significantly higher, compared to Achilles tendons without clinical enthesitis (respective median scores 1.0 and 0.5; p=0.04). In clinically unaffected entheses, HEMRIS abnormalities occurred in 44/70 (63%) of Achilles tendons and in 23/70 (33%) of plantar fascia. At the Achilles tendon, local metabolic activity measured on PET/CT was weakly associated with the structural (rs=0.25, p=0.03) and total HEMRIS (rs=0.26, p=0.03). CONCLUSION: This study revealed a high prevalence of subclinical HEMRIS abnormalities and discrepancy between HEMRIS and clinical and PET/CT findings. This may suggest that the HEMRIS is a sensitive method for detection of inflammatory and structural disease of enthesitis at the Achilles tendon and plantar fascia, although the clinical significance of these MRI findings remains to be determined in longitudinal studies.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Kleinrensink NJ, Foppen W, Ten Katen I, et al. Comparison of the Heel Enthesitis MRI Scoring System (HEMRIS) with clinical enthesitis and local metabolic activity on PET-CT. RMD Open. 2020. PMID: 33277402. doi:10.1136/rmdopen-2020-001424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。